Tangent Medical Technologies
Intravenous catheters and associated products for the improvement of infusion therapy
About Tangent Medical Technologies
Tangent Medical Technologies was a development-stage medical device company that operated in the intravenous (IV) therapy market. The firm was established in 2009 as a spin-off from the University of Michigan's Medical Innovation Center. Its conception was based on technology licensed from the university, developed by the company's technical founders: Adrienne Harris, Elyse Kemmerer, Steven White, and Merrell Sami, who were all Fellows at the center. The company focused on creating and commercializing products for IV therapy, targeting a market estimated at $1.3 billion.
The company's flagship product was the NovaCath™ Secure IV Catheter System. This system was designed as a pre-assembled, closed IV catheter that integrated advanced catheter stabilization, passive needle encapsulation, tubing management, and blood control. A key feature was its internal 180-degree fluid path, which eliminated the need for an external J-loop, thereby reducing the risk of snags and dislodgement. The design aimed to improve safety for healthcare workers by minimizing needlestick injuries and blood exposure, while also enhancing patient comfort. The NovaCath system received FDA 510(k) clearance in September 2012, a significant milestone that paved the way for its commercialization.
Following its founding, Tangent Medical Technologies secured initial seed funding from angel investors. In November 2011, it closed a $4.5 million Series A financing round, co-led by Arboretum Ventures and Flagship Ventures. This was followed by another funding round of $8.6 million in late 2012 after receiving FDA approval. The company began accepting commercial orders for the NovaCath system in mid-2013. Ultimately, Tangent Medical Technologies was acquired by ICU Medical, Inc. on April 4, 2016, for $2.6 million.
Source: Dealroom company dataNews
Open roles
Tangent Medical Technologies in the Ann Arbor ecosystem
The Tangent Medical Technologies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Ann Arbor Spark
Osage University Partners
Series A2 investors entered at this stage
Arboretum Ventures
Flagship Pioneering
Series B and later1 investor entered at this stage
GE Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Tangent Medical Technologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Tangent Medical Technologies on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.